Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
CGEN:NASDAQ
Compugen Ltd
$3.10
+6.16%
(+0.18) 1D
$3.14
+1.29% (+0.040)
After hours
Closed: Apr 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CGEN...
Open
$3.00
High
$3.24
Low
$2.95
Mkt. cap
293.12M
Avg. vol.
352.24K
Volume
1.25M
P/E ratio
8.23
52-wk high
$3.24
52-wk low
$1.23
EPS
$0.38
Beta
2.77
Shares outstanding
94.55M
No. of employees
75
News stories
From sources across the web
Profile
Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big companies such as Novartis AG, Abbot Laboratories and Pfizer Inc. Subsequently, Compugen made a decision to become a drug development company with its own internal pipeline, and in 2010, decided to a focus on oncology and immunology. OncoMed Pharmaceuticals and Five Prime Therapeutics are among Compugen's competitors. Wikipedia
About Compugen Ltd
CEOAnat Cohen-Dayag
Employees75
FoundedFeb 10, 1993
Headquarters-
SectorBiotechnology
Websitecgen.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.28M
1.26M
1.89M
67.33M
Cost of goods sold
2.40M
1.66M
1.65M
3.54M
Cost of revenue
2.40M
1.66M
1.65M
3.54M
Research and development expenses
5.77M
5.64M
5.80M
5.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.51M
2.38M
2.33M
2.21M
Operating expense
8.28M
8.02M
8.13M
7.75M
Total operating expenses
10.68M
9.69M
9.78M
11.29M
Operating income
-8.40M
-8.43M
-7.89M
56.04M
Other non operating income
-
-
-
-28.00K
EBT including unusual items
-7.15M
-7.36M
-6.94M
56.84M
EBT excluding unusual items
-7.15M
-7.36M
-6.94M
56.34M
Income tax expense
31.00K
-17.00K
40.00K
-
Effective tax rate
-0.43%
0.23%
-0.58%
-
Other operating expenses
-
-
-
-
Net income
-7.18M
-7.34M
-6.98M
56.84M
Net profit margin
-314.40%
-584.09%
-369.06%
84.42%
Earnings per share
-0.08
-0.08
-0.07
0.60
Interest and investment income
1.24M
1.07M
954.00K
636.00K
Interest expense
-
-
-
-
Net interest expenses
1.24M
1.07M
954.00K
636.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.27M
-8.31M
-7.77M
56.16M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer